Drug intelligence / Profile preview

Convalescent plasma (National Institute of Health Research and Development, Indonesia)

Development stage
Unknown
Lead developer
National Institute of Health Research and Development
Administration
Intravenous
01

Overview

Convalescent plasma is a biological therapy consisting of plasma collected from individuals who have recovered from COVID-19 and developed antibodies against the SARS-CoV-2 virus. This specific intervention is being evaluated by the National Institute of Health Research and Development of the Indonesian Ministry of Health as an adjunct therapy for hospitalized patients with moderate to severe COVID-19. The mechanism involves the passive transfer of neutralizing antibodies and other proteins to the recipient, which can help neutralize the virus, reduce viral load, and modulate the immune response. The PlaSenTer trial is a Phase 2/3 randomized, open-label study conducted in Indonesia to assess safety and clinical outcomes in a low-to-middle-income country (LMIC) setting.

Other names
Convalescent plasma treatmentCPUji Klinik Pemberian Plasma Konvalesen Sebagai Terapi Tambahan COVID-19
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on Convalescent plasma (National Institute of Health Research and Development, Indonesia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convalescent plasma (National Institute of Health Research and Development, Indonesia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call